Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.435    -0.005 (-0.20%)
Bid:
2.43
Ask:
2.44
Spread: 0.01 (0.412%)
Market Cap: $8.03b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

1st Quarter Results

12 May 2026 10:18

RNS Number : 9495D
Commercial Intnl Bank (Egypt) SAE
12 May 2026
 
http://www.rns-pdf.londonstockexchange.com/rns/9495D_1-2026-5-12.pdf

Condensed Separate Interim Statement of Financial Position as at March 31, 2026

Notes

Mar. 31, 2026

 

Dec. 31, 2025

 

 

 

Assets

 

Cash and balances at the central bank

14

91,222,851

 

88,094,579

Due from banks

15

171,464,712

 

136,581,804

Loans and advances to banks, net

17

55,185,042

 

34,440,770

Loans and advances to customers, net

18

545,902,541

 

503,361,099

Derivative financial instruments

515,109

 

620,349

Financial investments

 

 

 

- Financial Assets at Fair Value through OCI

19.1

374,988,506

 

375,180,260

- Financial Assets at Amortized cost

19.1

264,070,109

 

234,685,457

Investments in subsidiaries and associates

20

1,257,430

 

1,157,430

Non-current assets held for sale

32

279,104

 

279,104

Other assets

21

49,136,404

 

53,904,113

Deferred tax assets

1,185,389

 

2,410,347

Property and equipment

22

5,587,553

5,437,519

Total assets

 

1,560,794,750

 

1,436,152,831

 

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

23

14,337,104

 

3,796,866

Due to customers

24

1,210,058,565

 

1,105,355,617

Derivative financial instruments

81,585

 

137,802

Current income tax liabilities

5,380,432

 

20,570,313

Other liabilities

25

60,117,408

 

25,411,706

Issued debt instruments

26

5,455,820

 

4,761,558

Other loans

34,530,873

 

30,471,499

Other provisions

27

16,594,297

15,632,737

Total liabilities

 

1,346,556,084

1,206,138,098

 

Equity

 

 

 

Issued and paid capital

33,779,361

 

33,779,361

Reserves

135,250,237

 

105,426,594

Reserve for employee stock ownership plan (ESOP)

2,715,948

 

2,343,532

Retained earnings*

 

42,493,120

88,465,246

Total equity and net profit for the period / year

 

214,238,666

230,014,733

 

Total liabilities and equity

 

1,560,794,750

1,436,152,831

 

The accompanying notes are an integral part of these financial statements.

 

(Review report attached)

 

*

Including net profit for the period

 

 

Condensed Separate Interim Income Statement for The Period Ended March 31, 2026

 

 

Notes

 

Mar. 31, 2026

 

Mar. 31, 2025

 

 

 

 

 

 

 

 

 

 

Interest and similar income

 

53,038,335

 

52,299,641

 

Interest and similar expense

 

(23,508,947)

(27,003,143)

 

Net interest income

 

 

29,529,388

25,296,498

 

 

 

 

 

 

Fee and commission income

 

4,407,520

 

3,510,324

 

Fee and commission expense

 

(2,221,186)

(1,586,144)

 

Net fee and commission income

 

 

2,186,334

1,924,180

 

 

 

 

 

 

Dividend income

 

24,830

 

12,751

 

Net trading income

9

 

418,338

 

641,395

 

Profits (losses) on financial investments 

19.2

 

168,162

 

376,684

 

Administrative expenses

 

(4,971,613)

 

(3,748,977)

 

Other operating income (expenses)

10

 

(2,426,872)

 

(1,735,421)

 

Release (charges) for ECL

11

532,097

(68,528)

 

Profit before income tax

 

25,460,664

22,698,582

 

 

 

 

 

 

Income tax expense

12

 

(6,304,551)

 

(6,514,216)

 

Deferred tax assets (liabilities)

12

 

(1,417,766)

411,246

 

Net profit for the period

 

 

17,738,347

 

16,595,612

 

 

 

 

 

Earnings per share

13

 

 

 

Basic

4.65

 

4.37

 

Diluted

4.59

 

4.32

 

 

 

 

 

 

 

 

 

 

 

 

Islam Zekry

Hisham Ezz Al-Arab

 

Group CFO & Executive Board Member

CEO & Executive Board Member

 

Condensed Separate Interim Statement of Comprehensive Income for The Period Ended March 31, 2026

 

 

Mar. 31, 2026

 

Mar. 31, 2025

 

 

 

 

 

 

 

Net profit for the period

 

 

17,738,347

16,595,612

 

 

 

 

Net change on financial assets at fair value through comprehensive income after tax

 

(4,612,788)

 

2,141,325

Effect of ECL on debt instruments measured at fair value through OCI

 

 

(263,772)

841,407

Total comprehensive income for the period

 

 

12,861,787

 

19,578,344

 

 

Condensed Separate Interim Cash Flows for The Period Ended March 31, 2026

 

Notes

Mar. 31, 2026

 

Mar. 31, 2025

 

 

 

Cash flow from operating activities

 

 

Profit before income tax

 

25,460,664

 

22,698,582

Adjustments to reconcile profits to net cash provided by operating activities

 

 

 

Fixed assets depreciation

22

544,724

353,476

Impairment release/charge for credit losses (loans and advances to customers and banks)

11

(328,665)

(1,099,420)

Net charge/release for other provisions

27

989,760

317,074

Impairment release/charge for credit losses (due from banks)

11

7,565

144,661

Impairment release/charge for credit losses (financial investments)

11

(210,997)

1,023,287

Exchange revaluation differences for financial assets at fair value through OCI and AC

(23,298,906)

212,785

Revaluation differences impairment charge for Financial Assets at Fair value through OCI

534,661

(13,337)

Revaluation differences impairment charge for Financial Assets at Amortized cost

51,512

1,240

Revaluation differences impairment charge for due from banks

19,270

-

Net utilized/recovered for other provisions

27

(1,152,649)

(520)

Exchange revaluation differences of other provisions

27

1,124,449

103,160

Profits/losses from selling property and equipment

-

(6,006)

Profits/losses from selling financial investments at fair value through OCI

19.2

(168,162)

(195,124)

Profits/losses from selling investments in associates

19.2

-

(181,560)

Share based payments

 

372,416

 

316,185

Operating profits before changes in operating assets and liabilities

 

3,945,642

 

23,674,483

 

 

 

Net decrease / increase in assets and liabilities

 

 

 

Due from banks

527,549

121,695,741

Derivative financial instruments

68,390

(142,036)

Loans and advances to banks and customers

(62,957,049)

(26,329,852)

Other assets

5,056,275

6,045,337

Due to banks

23

10,540,238

1,734,021

Due to customers

24

104,702,948

28,224,178

Current income tax obligations paid

(924,119)

(948,354)

Other liabilities

 

(6,132,228)

(1,891,062)

Net cash generated from (used in) operating activities

 

54,827,646

 

152,062,456

 

 

 

Cash flow from investing activities

 

 

 

Proceeds from sale of investments in associates

-

226,698

Payments for investment in subsidiaries

(100,000)

(140,000)

Payments for purchases of property, equipment and branches construction

(983,324)

(3,193,660)

Proceeds from selling property and equipment

10

-

6,006

Proceeds from redemption of financial assets at amortized cost

8,104,535

2,537,401

Payments for purchases of financial assets at amortized cost

(35,484,752)

(23,457,385)

Payments for purchases of financial assets at fair value through OCI

(45,986,599)

(29,004,342)

Proceeds from selling financial assets at fair value through OCI

62,163,317

6,611,128

Net cash generated from (used in) investing activities

 

(12,286,823)

(46,414,154)

 

Condensed Separate Interim Cash Flows for The Period Ended March 31, 2026 (Cont.)

 

Mar. 31, 2026

 

Mar. 31, 2025

 

 

 

Cash flow from financing activities

 

 

 

Other loans

4,059,374

(13,765)

Dividends

(8,742,653)

(6,552,255)

Issued debt instruments

694,262

(22,830)

Net cash generated from (used in) financing activities

(3,989,017)

(6,588,850)

 

 

 

Net increase (decrease) in cash and cash equivalent during the period

38,551,806

99,059,452

Beginning balance of cash and cash equivalent

141,266,643

227,028,744

Cash and cash equivalent at the end of the period

 

179,818,449

 

326,088,196

 

 

 

Cash and cash equivalent comprise:

 

 

 

Cash and balances at the central bank

14

91,222,851

 

67,709,656

Due from banks

171,624,229

 

314,289,639

Treasury bills and other governmental notes

16

129,038,860

116,517,989

Obligatory reserve balance with CBE

(70,980,930)

 

(43,718,398)

Due from banks with maturity more than three months

(12,048,530)

(14,867,792)

Treasury bills and other governmental notes with maturity more than three months

 

(129,038,031)

(113,842,898)

Total cash and cash equivalent

 

179,818,449

 

326,088,196

Condensed Separate Interim Statement of Changes in Shareholders' Equity

 

Mar. 31, 2025

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Special reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

Beginning Balance

30,431,580

6,208,674

62,422,792

1,549,445

-

22,818

(7,095,741)

17,924

56,260,451

1,868,235

151,686,178

 

Transferred to reserves

-

2,771,284

18,971,298

-

-

2,246

-

-

(21,744,828)

-

-

 

Dividend paid

-

-

-

-

-

-

-

-

(14,714,434)

-

(14,714,434)

 

Net profit for the period

-

-

-

-

-

-

-

-

16,595,612

-

16,595,612

 

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

-

2,141,325

-

-

-

2,141,325

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

(2,628)

2,628

-

-

 

Effect of ECL on debt instruments measured at fair value through OCI

-

-

-

-

-

-

841,407

-

-

-

841,407

 

Cost of employees' stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

316,185

316,185

 

 Ending Balance

30,431,580

8,979,958

81,394,090

1,549,445

-

25,064

(4,113,009)

15,296

36,399,429

2,184,420

156,866,273

 

 

 

 

Mar. 31, 2026

Issued and paid capital

Legal reserve

General reserve

General risk reserve

Special reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning Balance

33,779,361

8,979,958

79,110,551

1,549,445

13,145,012

25,064

2,601,268

15,296

88,465,246

2,343,532

230,014,733

 

Transferred to reserves

-

4,089,832

30,606,170

-

-

13,005

-

-

(34,709,007)

-

-

 

Dividends paid

-

-

-

-

-

-

-

-

(29,010,270)

-

(29,010,270)

 

Net profit for the period

-

-

-

-

-

-

-

-

17,738,347

-

17,738,347

 

Net change on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(4,612,788)

-

-

-

(4,612,788)

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

(8,804)

8,804

-

-

 

Effect of ECL on debt instruments measured at fair value through OCI

-

-

-

-

-

-

(263,772)

-

-

-

(263,772)

 

Cost of employees' stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

372,416

372,416

 

 Ending Balance

33,779,361

13,069,790

109,716,721

1,549,445

13,145,012

38,069

(2,275,292)

6,492

42,493,120

2,715,948

214,238,666

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFGPUPAAUPQUAP
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.